Emergent BioSolutions (EBS) Amortization - Intangibles (2018 - 2026)
Emergent BioSolutions (EBS) posted quarterly Amortization - Intangibles of $16.5 million for Q1 2026, up 1.23% year-over-year from $16.3 million in Q1 2025, and up 1.23% quarter-over-quarter from $16.3 million in Q4 2025.
Emergent BioSolutions (EBS) Amortization - Intangibles (2018 - 2026) Analysis & Trends
Emergent BioSolutions' Amortization - Intangibles history runs 9 years deep, the most recent figure standing at $16.5 million for Q1 2026.
- In Q1 2026, Amortization - Intangibles rose 1.23% year-over-year to $16.5 million; the TTM figure through Mar 2026 stood at $65.3 million (changed 0.15% YoY), while the FY2025 annual figure was $65.1 million, changed 0.0% from the prior year.
- Amortization - Intangibles for Q1 2026 stood at $16.5 million, up from $16.3 million in the prior quarter.
- The five-year high for Amortization - Intangibles was $17.9 million in Q4 2022, with the low at $14.0 million in Q1 2022.
- The 5-year median for Amortization - Intangibles is $16.3 million (2023), against an average of $16.0 million.
- The sharpest annual moves came in 2022 and 2023: Amortization - Intangibles gained 27.86% in 2022, then slipped 9.5% in 2023.
- Emergent BioSolutions' Amortization - Intangibles stood at $17.9 million in 2022, then dropped by 9.5% to $16.2 million in 2023, then increased by 0.62% to $16.3 million in 2024, then slipped by 0.0% to $16.3 million in 2025, then gained by 1.23% to $16.5 million in 2026.
- Business Quant data shows EBS's Amortization - Intangibles at $16.5 million in Q1 2026, $16.3 million in Q4 2025, and $16.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Emergent BioSolutions | 261.35 Mn | 120.45 Mn | 137.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.20 Mn |
| Mar 31, 2026 | 16.50 Mn |
| Dec 31, 2025 | 16.30 Mn |
| Sep 30, 2025 | 16.30 Mn |
| Jun 30, 2025 | 16.20 Mn |
| Mar 31, 2025 | 16.30 Mn |
| Dec 31, 2024 | 16.30 Mn |
| Sep 30, 2024 | 16.30 Mn |
| Jun 30, 2024 | 16.30 Mn |
| Mar 31, 2024 | 16.20 Mn |
| Dec 31, 2023 | 16.20 Mn |
| Sep 30, 2023 | 16.30 Mn |
| Jun 30, 2023 | 16.10 Mn |
| Mar 31, 2023 | 17.00 Mn |
| Dec 31, 2022 | 17.90 Mn |
| Sep 30, 2022 | 14.00 Mn |
| Jun 30, 2022 | 14.00 Mn |
| Mar 31, 2022 | 14.00 Mn |
| Dec 31, 2021 | 14.00 Mn |
| Sep 30, 2021 | 14.50 Mn |